a16z Podcast: Move Fast But Don't Break Things (When It Comes to Computational Biology)
The a16z Show14 Kesä 2016

a16z Podcast: Move Fast But Don't Break Things (When It Comes to Computational Biology)

The mindset of "move fast and break things", while great for code, isn't exactly great for the human body. So adding computation to biology -- especially in the slow-moving pharmaceutical industry, where drug approval can take years -- brings with it both opportunities (like drastically faster discovery and assessment) and challenges (the need for hard evidence, not just soft-ware). But there's more: We don't want just better outcomes for healthcare. We want better outcomes at a cheaper price.

And that's where machine learning comes in. The benefits of such computation -- i.e., software -- can provide a powerful, frictionless, and far more cost-effective tool for biopharmaceutical research ... but it requires data. So who provides that data? Is it the pharmaceutical companies, or the payers (insurance)? How are organizations incented to overcome intellectual property silos in sharing their data? Especially since it was only relatively recently, Jeff Kindler (the former CEO of the world's largest pharmaceutical company, Pfizer) reminds us in this episode of the a16z Podcast, that the FDA even allowed data to be put in computers vs. on paper.

But there's a reason the self-driving car was pushed out of the software and not the auto industry, argues TwoXAR co-founder and CEO Andrew Radin -- and it has to do with the unique nature of the developer's mindset applied to novel problems. The deterministic nature of Moore's Law -- it's not a matter of if, but when -- plays a role too, observes a16z bio fund general partner Vijay Pande. There are things that big data and simulations will be able to accomplish that a hundred lab experiments on animals can't. Still, the two mindsets will have to merge, so we can move fast ... but without compromising quality, safety, and reliability. That's the big difference between computer science and biology after all.

image: mattza/ Flickr

Stay Updated:

Find a16z on YouTube: YouTube

Find a16z on X

Find a16z on LinkedIn

Listen to the a16z Show on Spotify

Listen to the a16z Show on Apple Podcasts

Follow our host: https://twitter.com/eriktorenberg

Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Jaksot(1000)

Building Blackstone, Backing Costco, with Tony James

Building Blackstone, Backing Costco, with Tony James

David Haber speaks with Tony James about building enduring firms across multiple eras of finance. From joining DLJ when it was a subscale firm to helping grow Blackstone into one of the largest asset ...

5 Touko 1h 23min

Sarah Rogers: Free Speech, AI Diplomacy, and What America Owes Its Allies

Sarah Rogers: Free Speech, AI Diplomacy, and What America Owes Its Allies

Katherine Boyle speaks with Sarah Rogers, Under Secretary for Public Diplomacy, about the intersection of AI, free speech, and global information systems. They discuss how major technological shifts, ...

4 Touko 24min

Balaji and Taylor Lorenz on AI and Media

Balaji and Taylor Lorenz on AI and Media

Theo Jaffee speaks with Balaji Srinivasan and Taylor Lorenz about how AI is reshaping media, trust, and online communication. Building on prior public disagreements between the two, the conversation r...

1 Touko 51min

Workday’s Last Workday? AI and the Future of Enterprise Software

Workday’s Last Workday? AI and the Future of Enterprise Software

Elena Burger speaks with Joe Schmidt, partner on the enterprise team at a16z, about the future of enterprise software in the age of AI. Using Workday as a case study, they discuss why many of today’s ...

30 Huhti 29min

The Shift in Global Drug Development

The Shift in Global Drug Development

Theo Jaffee and Gabriel Dickinson speak with Cremieux about China’s rapid rise to the top of global clinical trial output. They discuss the regulatory reforms that accelerated China’s progress, the su...

29 Huhti 57min

John and Patrick Collison on Stripe's Growth, Agent Commerce, and the Future of Software

John and Patrick Collison on Stripe's Growth, Agent Commerce, and the Future of Software

This interview with Stripe cofounders John and Patrick Collison originally aired on TBPN. They discuss Stripe's 34% growth and new employee tender offer, how agent commerce and stablecoins may require...

28 Huhti 20min

Ben Horowitz on Venture Capital and AI

Ben Horowitz on Venture Capital and AI

Anjney Midha, founder of AMP PBC, speaks with Ben Horowitz, cofounder of a16z, about how venture capital changed from a small, relationship-driven business into a scalable system for backing new techn...

27 Huhti 1h 9min

AI Inside the Enterprise

AI Inside the Enterprise

Steven Sinofsky, board partner at a16z, Aaron Levie, CEO of Box, and Martin Casado, general partner at a16z, discuss the reality of AI inside enterprises. They cover the gap between Silicon Valley and...

24 Huhti 1h

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
psykopodiaa-podcast
rss-rahapodi
mimmit-sijoittaa
rss-oivalluksia-rahasta-elamasta
hyva-paha-johtaminen
ostan-asuntoja-podcast
rss-rahamania
rahapuhetta
rss-sisalto-kuntoon
rss-paasipodi
rss-yritys-ja-erehdys
inderespodi
rss-sami-miettinen-neuvottelija
lakicast
rss-lahtijat
rss-startup-ministerio
rss-kaikki-somesta
rss-karon-grilli
rss-lentopaivakirjat